Lema, L.; Pérez-García, J.M.; Blanch, S.; Balmaña, J.; García-Sáenz, J.Á.; Vegas, E.F.; Jiménez, B.; de la Haba, J.; Campolier, M.; Shimizu, E.;
et al. Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline BRCA Mutation. Cancers 2025, 17, 1744.
https://doi.org/10.3390/cancers17111744
AMA Style
Lema L, Pérez-García JM, Blanch S, Balmaña J, García-Sáenz JÁ, Vegas EF, Jiménez B, de la Haba J, Campolier M, Shimizu E,
et al. Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline BRCA Mutation. Cancers. 2025; 17(11):1744.
https://doi.org/10.3390/cancers17111744
Chicago/Turabian Style
Lema, Laura, José Manuel Pérez-García, Salvador Blanch, Judith Balmaña, José Ángel García-Sáenz, Elena Filipovich Vegas, Begoña Jiménez, Juan de la Haba, Marta Campolier, Eileen Shimizu,
and et al. 2025. "Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline BRCA Mutation" Cancers 17, no. 11: 1744.
https://doi.org/10.3390/cancers17111744
APA Style
Lema, L., Pérez-García, J. M., Blanch, S., Balmaña, J., García-Sáenz, J. Á., Vegas, E. F., Jiménez, B., de la Haba, J., Campolier, M., Shimizu, E., Alcalá-López, D., Sampayo-Cordero, M., Cortés, J., & Llombart-Cussac, A.
(2025). Niraparib Plus Aromatase Inhibitors for Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with a Germline BRCA Mutation. Cancers, 17(11), 1744.
https://doi.org/10.3390/cancers17111744
